JPWO2022087019A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022087019A5
JPWO2022087019A5 JP2023548545A JP2023548545A JPWO2022087019A5 JP WO2022087019 A5 JPWO2022087019 A5 JP WO2022087019A5 JP 2023548545 A JP2023548545 A JP 2023548545A JP 2023548545 A JP2023548545 A JP 2023548545A JP WO2022087019 A5 JPWO2022087019 A5 JP WO2022087019A5
Authority
JP
Japan
Prior art keywords
hla
complex
interrogated
eliciting
inhibited
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023548545A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023546300A5 (https=
JP2023546300A (ja
Publication date
Priority claimed from GBGB2016659.1A external-priority patent/GB202016659D0/en
Priority claimed from GBGB2101665.4A external-priority patent/GB202101665D0/en
Application filed filed Critical
Priority claimed from PCT/US2021/055682 external-priority patent/WO2022087019A1/en
Publication of JP2023546300A publication Critical patent/JP2023546300A/ja
Publication of JP2023546300A5 publication Critical patent/JP2023546300A5/ja
Publication of JPWO2022087019A5 publication Critical patent/JPWO2022087019A5/ja
Pending legal-status Critical Current

Links

JP2023548545A 2020-10-20 2021-10-19 細胞治療のための方法および組成物 Pending JP2023546300A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB2016659.1 2020-10-20
GBGB2016659.1A GB202016659D0 (en) 2020-10-20 2020-10-20 Methods and compositions for cellular therapy
GBGB2101665.4A GB202101665D0 (en) 2021-02-05 2021-02-05 Methods and compositions for cellular therapy
GB2101665.4 2021-02-05
PCT/US2021/055682 WO2022087019A1 (en) 2020-10-20 2021-10-19 Methods and compositions for cellular therapy

Publications (3)

Publication Number Publication Date
JP2023546300A JP2023546300A (ja) 2023-11-01
JP2023546300A5 JP2023546300A5 (https=) 2024-10-25
JPWO2022087019A5 true JPWO2022087019A5 (https=) 2024-10-25

Family

ID=81290046

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023548545A Pending JP2023546300A (ja) 2020-10-20 2021-10-19 細胞治療のための方法および組成物

Country Status (8)

Country Link
US (1) US20240124551A1 (https=)
EP (1) EP4232468A4 (https=)
JP (1) JP2023546300A (https=)
KR (1) KR20230110258A (https=)
AU (1) AU2021364550A1 (https=)
CA (1) CA3196346A1 (https=)
GB (1) GB2619410A (https=)
WO (1) WO2022087019A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102776627B1 (ko) 2019-05-06 2025-03-06 토마스 말콤 암 종양에 대한 맞춤화된 하이포면역 나노소포체 전달 시스템
GB202205771D0 (en) * 2022-04-20 2022-06-01 Replay Holdings Llc Methods and compositions for cellular therapy
GB202316281D0 (en) * 2023-10-24 2023-12-06 Replay Holdings Inc Methods and compositions for modulating immune cell activity in cellular therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10503379A (ja) * 1994-07-29 1998-03-31 デイド・インターナショナル・インコーポレーテッド Mhc複合体およびその用途
US6211342B1 (en) * 1996-07-18 2001-04-03 Children's Hospital Medical Center Multivalent MHC complex peptide fusion protein complex for stimulating specific T cell function
GB0107628D0 (en) * 2001-03-27 2001-05-16 Avidex Ltd Substances
GB0115071D0 (en) * 2001-06-20 2001-08-15 Avidex Ltd Substances
US8895020B2 (en) * 2002-04-19 2014-11-25 Washington University Single chain trimers and uses therefor
US9765330B1 (en) * 2015-01-09 2017-09-19 Nant Holdings Ip, Llc Compositions and methods for reduction of allograft recognition and rejection
WO2018089661A1 (en) * 2016-11-09 2018-05-17 La Jolla Institute For Allergy And Immunology Use of c-terminally extended peptides to disrupt inhibitor nk cell receptor interactions with mhc i
CN110177869A (zh) * 2017-01-13 2019-08-27 加利福尼亚大学董事会 免疫改造的多能细胞
RU2764620C2 (ru) * 2018-07-10 2022-01-18 Общество С Ограниченной Ответственностью "Бетарут" Способ и устройство жидкой ковки двойного действия
US12331318B2 (en) * 2018-07-13 2025-06-17 Lothar Germeroth Non-immunogenic engineered tissue and methods of producing and using the same
WO2020051373A1 (en) * 2018-09-06 2020-03-12 Optumsoft, Inc. Automatic generation of an efficient rule set implementation

Similar Documents

Publication Publication Date Title
JP2006523595A5 (https=)
JP2007518723A5 (https=)
JP2006516528A5 (https=)
JP2004538039A5 (https=)
JP2005508306A5 (https=)
JP2003520017A5 (https=)
JP2021512071A5 (https=)
JP2013501834A5 (https=)
JP2022040018A5 (https=)
JP2021533273A5 (https=)
JP2007051233A5 (https=)
JP2021514452A5 (https=)
JP2006512466A5 (https=)
JPWO2022087019A5 (https=)
JP2021073989A5 (https=)
JPWO2019143858A5 (https=)
JPWO2020249002A5 (https=)
JP2009055850A5 (https=)
JPWO2020093023A5 (https=)
JPWO2021251324A5 (https=)
JP2024020181A5 (https=)
JPWO2021046125A5 (https=)
JP2020184582A5 (https=)
JPWO2023106136A5 (https=)
JP2024029405A5 (https=)